Autopsy report · NCT02259517

An fMRI Study of Stimulant vs. Non-Stimulant Treatment of ADHD

“Recruitment/enrollment ended early due to the COVID-19 pandemic”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 7 years 2 months before it stopped.
• 38 participants enrolled.
• Results were posted on the registry 1 year 3 months after it ended.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

New York State Psychiatric Institute

Sponsor type

University, hospital or other

Conditions

Attention Deficit Hyperactivity Disorder

Interventions

Guanfacine; Lisdexamfetamine

Participants

38

Sites

1

Countries

United States

Trials that died the same way

• Diet and Exercise Frailty Intervention in Cardiac Device Patients
  “Due to COVID-19 Pandemic Recruitment was not started” (84% match in meaning)
• Sleep, Insulin Sensitivity, and Weight in Adolescents Post-bariatric Surgery
  “COVID-19 pandemic impacted recruitment” (81% match in meaning)
• Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes
  “Enrollment halted prematurely due to the Covid-19 pandemic” (80% match in meaning)
• Pathology and Imaging in Kidney Allografts
  “recruitment difficulties due to impact of COVID-19 pandemic” (80% match in meaning)
• Treating Stimulant Addiction With Repetitive Transcranial Magnetic Stimulation
  “COVID-19 pandemic adversely affected recruitment.” (79% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.